JP2017505327A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505327A5
JP2017505327A5 JP2016550611A JP2016550611A JP2017505327A5 JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5 JP 2016550611 A JP2016550611 A JP 2016550611A JP 2016550611 A JP2016550611 A JP 2016550611A JP 2017505327 A5 JP2017505327 A5 JP 2017505327A5
Authority
JP
Japan
Prior art keywords
oxy
pyridin
trifluoromethyl
alkyl
quinolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016550611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6532474B2 (ja
JP2017505327A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/014380 external-priority patent/WO2015119998A1/en
Publication of JP2017505327A publication Critical patent/JP2017505327A/ja
Publication of JP2017505327A5 publication Critical patent/JP2017505327A5/ja
Application granted granted Critical
Publication of JP6532474B2 publication Critical patent/JP6532474B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016550611A 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用 Expired - Fee Related JP6532474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461936397P 2014-02-06 2014-02-06
US61/936,397 2014-02-06
PCT/US2015/014380 WO2015119998A1 (en) 2014-02-06 2015-02-04 6-heteroaryloxy- and 6-aryloxy-quinoline-2-carboxamides and uses thereof

Publications (3)

Publication Number Publication Date
JP2017505327A JP2017505327A (ja) 2017-02-16
JP2017505327A5 true JP2017505327A5 (enExample) 2018-03-15
JP6532474B2 JP6532474B2 (ja) 2019-06-19

Family

ID=52484589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016550611A Expired - Fee Related JP6532474B2 (ja) 2014-02-06 2015-02-04 6−ヘテロアリールオキシ−および6−アリールオキシ−キノリン−2−カルボキシアミドならびにその使用

Country Status (14)

Country Link
US (3) US9452986B2 (enExample)
EP (1) EP3102569A1 (enExample)
JP (1) JP6532474B2 (enExample)
KR (1) KR20160118345A (enExample)
CN (1) CN106458985B (enExample)
AU (1) AU2015214366B2 (enExample)
BR (1) BR112016017996A2 (enExample)
CA (1) CA2938719A1 (enExample)
HK (1) HK1231471A1 (enExample)
IL (1) IL247014A0 (enExample)
MX (1) MX2016010056A (enExample)
RU (1) RU2016135637A (enExample)
SG (1) SG11201606367YA (enExample)
WO (1) WO2015119998A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI621618B (zh) 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
TW201444849A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途
TW201444821A (zh) 2013-03-13 2014-12-01 Janssen Pharmaceutica Nv 經取代之哌啶化合物及其作為食慾素受體調節劑之用途
IL311677B2 (en) 2014-01-13 2025-06-01 Aurigene Oncology Ltd Bicyclic heterocyclyl derivatives as irak4 inhibitors
MX2016010056A (es) * 2014-02-06 2016-11-15 Abbvie Inc 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso.
CA2952188A1 (en) * 2014-06-20 2015-12-23 Aurigene Discovery Technologies Limited Substituted indazole compounds as irak4 inhibitors
JP6715239B2 (ja) * 2014-09-11 2020-07-01 ヤンセン ファーマシューティカ エヌ.ベー. 置換2−アザ二環式化合物及びオレキシン受容体調節因子としてのその使用
MX386261B (es) 2015-10-07 2025-03-18 Univ Arizona Inhibidores de sumoilacion de crmp2 y usos de los mismos
PL3359541T3 (pl) * 2015-10-09 2021-01-11 AbbVie Overseas S.à r.l. N-SULFONYLOWANE PIRAZOLO[3,4-b]PIRYDYNO-6-KARBOKSAMIDY I SPOSÓB ZASTOSOWANIA
BR112019012822A2 (pt) 2016-12-22 2019-11-26 Bayer Ag 1,2,4-tiadiazolilpirrolonas e 1,2,4-tiadiazolil-hidantoínas e sais das mesmas e uso das mesmas como herbicidas
CN120267671A (zh) 2017-03-31 2025-07-08 奥锐金肿瘤有限公司 用于治疗血液病的化合物和组合物
JP7210483B2 (ja) * 2017-06-30 2023-01-23 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規アザキノリン誘導体
EP4410377A3 (en) 2017-10-31 2024-11-13 Curis, Inc. Compounds and compositions for treating hematological disorders
AU2019302534B2 (en) 2018-07-09 2024-10-03 Lieber Institute, Inc. Pyridazine compounds for inhibiting NaV1.8
SG11202100130QA (en) 2018-07-09 2021-02-25 Lieber Institute Inc Pyridine carboxamide compounds for inhibiting nav1.8
WO2020054657A1 (ja) 2018-09-10 2020-03-19 科研製薬株式会社 新規ヘテロ芳香族アミド誘導体及びそれを含有する医薬
EP3877356A4 (en) 2018-11-09 2022-06-22 Vivace Therapeutics, Inc. BICYCLIC LINKS
CA3126021A1 (en) 2019-01-11 2020-07-16 Naegis Pharmaceuticals Inc. Leukotriene synthesis inhibitors
AU2020257207B2 (en) * 2019-04-16 2026-06-04 Vivace Therapeutics, Inc. Bicyclic compounds
CA3214747A1 (en) 2021-04-08 2022-10-13 Reinhard Von Roemeling Combination therapies for the treatment of cancer
JP2025504498A (ja) * 2022-01-18 2025-02-12 成都康弘薬業集団股分有限公司 芳香族縮合環nav1.8阻害剤、及びその使用
PY2389146A (es) 2022-11-09 2025-06-23 Syngenta Crop Protection Ag Derivados de pirazol microbiocidas
EP4791725A1 (en) 2023-10-11 2026-08-19 Syngenta Crop Protection AG Microbiocidal pyridyl pyrazole derivatives
WO2025233384A1 (en) 2024-05-08 2025-11-13 Syngenta Crop Protection Ag Microbiocidal pyrazole compounds
WO2026008511A1 (en) 2024-07-02 2026-01-08 Syngenta Crop Protection Ag Microbiocidal quinoline-amide compounds
WO2026047037A1 (en) 2024-08-28 2026-03-05 Syngenta Crop Protection Ag Microbiocidal quinoline-amide compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663994B1 (en) * 2003-08-05 2012-03-07 Vertex Pharmaceuticals Incorporated Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
BRPI0518222A (pt) * 2004-10-19 2008-11-04 Hoffmann La Roche composto, processo para a sua manufatura, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de h3 e utilização dos mesmos
EP1888558B1 (en) * 2005-05-16 2011-10-05 Vertex Pharmaceuticals, Inc. Bicyclic derivatives as modulators of ion channels
GB0513692D0 (en) * 2005-07-04 2005-08-10 Karobio Ab Novel pharmaceutical compositions
AU2006286576B2 (en) * 2005-09-01 2012-06-14 F. Hoffmann-La Roche Ag Diaminopyrimidines as P2X3 and P3X2/3 modulators
AU2007243466B2 (en) 2006-04-26 2012-01-19 F. Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
EP2073806B1 (en) * 2006-10-12 2012-02-15 Xenon Pharmaceuticals Inc. Use of spiro-oxindole compounds as therapeutic agents
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
KR101605061B1 (ko) * 2009-05-29 2016-03-21 라퀄리아 파마 인코포레이티드 칼슘 또는 나트륨 채널 차단제로서의 아릴 치환된 카복사미드 유도체
US9051296B2 (en) * 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
US8394829B2 (en) * 2010-05-10 2013-03-12 Gilead Sciences, Inc. Bi-functional quinoline analogs
EP2630122B1 (en) * 2010-10-18 2016-11-30 RaQualia Pharma Inc Arylamide derivatives as ttx-s blockers
KR102226587B1 (ko) * 2013-01-31 2021-03-11 버텍스 파마슈티칼스 인코포레이티드 나트륨 채널의 조절제로서의 퀴놀린 및 퀴나졸린 아미드
MX2016010056A (es) * 2014-02-06 2016-11-15 Abbvie Inc 6-heteroariloxi o 6-ariloxi-quinolina-2-carboxamidas y metodos de uso.

Similar Documents

Publication Publication Date Title
RU2016135637A (ru) 6-гетероарилокси- и 6-арилоксихинолин-2-карбоксамиды и их применение
AU2024266099A1 (en) Spiro-heterocyclic inhibitors of kras g12c mutant proteins and uses thereof
ES2548532T3 (es) Compuestos de pirrolopirimidina como inhibidores de CDK4/6
JP6895439B2 (ja) IRAK4調節因子としてのピラゾロ[1,5a]ピリミジン誘導体
JP2014506929A5 (enExample)
AU2022265682A1 (en) 2-aminobenzothiazole compounds and methods of use thereof
EP4384160A1 (en) Heterocyclic compounds and methods of use
EP4479398A1 (en) Quinazoline compounds and use thereof as inhibtors of mutant kras proteins
JP2025533831A (ja) Kras g12c変異タンパク質のテザー型複素環式阻害剤及びその使用
CN111655695B (zh) 作为pde1抑制剂的取代的呋喃并嘧啶化合物
JP2015526394A5 (enExample)
HRP20210177T1 (hr) Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze
JP2015537010A5 (enExample)
JP2015522002A5 (enExample)
RU2014123316A (ru) Ингибиторы фосфодиэстеразы типа 10а
JP2018530557A5 (enExample)
JP2014534976A5 (enExample)
JP2019530739A5 (enExample)
RU2019115115A (ru) Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7
JP2017524007A5 (enExample)
JP2015533822A5 (enExample)
RU2015100209A (ru) Замещенные соединения тиофен- и фуран-конденсированного азолопиримидин-5-(6н)-она
JP2021504380A5 (enExample)
RU2015122895A (ru) Пуриновые ингибиторы человеческой фосфатидилинозит 3-киназы дельта
RU2020129785A (ru) Фармацевтические производные 6,5-гетеробициклического кольца